Food and Drug Administration
Studies Addressing Rare Neurodegenerative Diseases including ALS
Studies Addressing Rare Neurodegenerative Diseases including ALS is a funding opportunity from Food and Drug Administration.
Overview
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to…